Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for ...

Tevogen Bio is driven by a team of highly experienced industry leaders and distinguished scientists with drug development and ...

COO and President Ramses Erdtmann continuing at Biomea in current role.

Time frame The share buy-back program will start on March 26, 2025, and is expected to end no later than July 10, 2025 (unless Genmab terminates or suspends the program).

To maximize absorption, take the Prime Biome formula 30 minutes before the morning or afternoon meal. Daily consumption in ...

Allow us to present Alviona Tablets, the most well-liked weight loss supplement. Let's begin learning more about it today.

Avance Clinical CEO Yvonne Lungershausen emphasized the importance of these new partnerships and highlighted the value of ...

When VSD+ is used, excess heat or gas is pumped into the barns to speed up the process, though it can still take hours to kill animals. VSD+ has been increasingly used by the animal agriculture ...

Sight Sciences’ management is scheduled to present on Tuesday, April 8, 2025, at 12:45 pm PT / 3:45 pm ET. Interested parties may access a live and archived webcast of the fireside chat on the ...

Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable ...

RxSight’s management is scheduled to participate in a fireside chat on Tuesday, April 8, 2025, at 9:45 a.m. Pacific Time / 12:45 p.m. Eastern Time. A live and archived webcast of the presentation will ...

NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash ...